In Vitro-in Vivo Correlations

Examples of in Vitro-in Vivo Relationships with a Diverse Range of Quality R.J. Rackley. Dissolution Assay Development for in Vitro-in Vivo Correlations: Theory and Case Studies B.R. Rohrs, et al. In Vitro Dissolution Profile Comparison and IVIVR: Carbamazepine Case P. Sathe, et al. A General Framework for Non-Parametric Subject-Specific and Population Deconvolution Methods for in Vivo-in Vitro Correlation D. Verotta. Convolution-Based Approaches for in Vitro-in Vivo Correlation Modeling W.R. Gillespie. Approaches to IVIVR Modeling and Statistical Analysis A. Dunne, et al. Validation of in Vitro-in Vivo Correlation Models D. Young, et al. Examples of Developing in Vitro-in Vivo Relationships J. Butler. The Biopharmaceutic Drug Classification and Drugs Administered in Extended Release (ER) Formulations O.I. Corrigan. Investigating in in Vitro Drug Release Mechanisms Inside Dosage Forms: Monitoring Liquid Ingress in HPMC Hydrophilic Matrices Using Confocal Microscopy C.D. Melia, et al. Determination of Critical Manufacturing and Formulation Variables for a Hydrophilic Matrix Tablet Formulation Using an in Vitro Discriminatory Dissolution Method P. Stark, et al. 15 Additional Articles. Index.

[1]  E. Vonesh,et al.  Efficient inference for random-coefficient growth curve models with unbalanced data. , 1987, Biometrics.

[2]  J. Dressman,et al.  Mixing-tank model for predicting dissolution rate control or oral absorption. , 1986, Journal of pharmaceutical sciences.

[3]  T. Kararli.  Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.

[4]  G. Amidon,et al.  Analysis of models for determining intestinal wall permeabilities. , 1980, Journal of pharmaceutical sciences.

[5]  Y. Seta,et al.  Design and preparation of captopril sustained-release dosage forms and their biopharmaceutical properties , 1988 .

[6]  U. Klotz,et al.  Extrahepatic Metabolism of Drugs in Humans , 1994, Clinical pharmacokinetics.

[7]  U. Fuhr,et al.  Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule). , 1989, The American journal of medicine.

[8]  E. Piepmeier,et al.  Influence of physico-chemical properties of hydroxypropyl methylcellulose on naproxen release from sustained release matrix tablets , 1990 .

[9]  P. Artursson,et al.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.

[10]  Colonic drug absorption and metabolism , 1993 .

[11]  Martyn C. Davies,et al.  Structure and behaviour in hydrophilic matrix sustained release dosage forms: 3. The influence of pH on the sustained-release performance and internal gel structure of sodium alginate matrices , 1995 .

[12]  Thomas J. Raub,et al.  Biological Barriers to Protein Delivery , 1993, Pharmaceutical Biotechnology.

[13]  J. Keith Guillory,et al.  Solid Pharmaceutics: Mechanical Properties and Rate Phenomena. By Jens Thurø CARSTENSEN. Academic, 111 Fifth Ave., New York, NY 10003. 1980. 259 pp. 15 × 23 cm. Price $35.00 , 1981 .

[14]  Approaches to IVIVR modelling and statistical analysis. , 1997, Advances in experimental medicine and biology.

[15]  Effect of formulation and process variables on bioequivalency of nitrofurantoin II: in vivo-in vitro correlation. , 1978, Journal of pharmaceutical sciences.

[16]  N. Peppas,et al.  Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. , 1983, Journal of pharmaceutical sciences.

[17]  Patrick van der Smagt,et al.  Introduction to neural networks , 1995, The Lancet.

[18]  Lewis J. Leeson,et al.  In Vitro/In Vivo Correlations , 1995 .

[19]  M. Davies,et al.  Characterising drug release processes within controlled release dosage forms using the confocal laser scanning microscope , 1996 .

[20]  W. Higuchi,et al.  Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes , 1980 .

[21]  R. Minchin,et al.  Metabolism of drugs and other xenobiotics in the gut lumen and wall. , 1990, Pharmacology & therapeutics.

[22]  John E. Hogan,et al.  Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets , 1987 .

[23]  Malcolm Rowland,et al.  Clinical pharmacokinetics : concepts and applications , 1989 .

[24]  R. L. E. Schwarzenberger,et al.  Elementary Differential Equations , 1970 .

[25]  J. W. Moore,et al.  Mathematical comparison of dissolution profiles , 1996 .

[26]  A. Roy,et al.  The uptake of oestrone from the lumen of the isolated perfused rat gut. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.

[27]  D. F. Morrison,et al.  Multivariate Statistical Methods , 1968 .

[28]  Richard H. Jones.  Analysis of repeated measures , 1992 .

[29]  Stephen I. Gallant,et al.  Neural network learning and expert systems , 1993 .

[30]  H. Lennernäs.  Gastrointestinal absorption mechanisms: a comparison between animal and human models , 1994 .

[31]  V W Steinijans,et al.  Feasibility of in-vitro/in-vivo correlation in the case of a new sustained-release theophylline pellet formulation. , 1988, Arzneimittel-Forschung.

[32]  Jeffrey L. Elman,et al.  Finding Structure in Time , 1990, Cogn. Sci..

[33]  K. Hillgren,et al.  In vitro systems for studying intestinal drug absorption , 1995, Medicinal research reviews.

[34]  Clive G. Wilson,et al.  Physiological pharmaceutics : biological barriers to drug absorption , 1989 .

[35]  R. Wolfinger,et al.  Generalized linear mixed models a pseudo-likelihood approach , 1993 .

[36]  W. H. Barr,et al.  Differential absorption of amoxicillin from the human small and large intestine , 1994, Clinical pharmacology and therapeutics.